Auxilium Pharmaceuticals, Inc. - SWOT, Strategy and Corporate Finance Report
Published: July 2013 · Publisher: MarketLine
Auxilium Pharmaceuticals, Inc. - SWOT, Strategy and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings, etc.
- Description
- Table of Contents
- Ask a Question
Auxilium Pharmaceuticals, Inc. - SWOT, Strategy and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings, detailed financials, and corporate actions, providing a 360˚ view of the company.
Features:
- Detailed information on Auxilium Pharmaceuticals, Inc. required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Auxilium Pharmaceuticals, Inc. in the form of a SWOT analysis
- An in-depth view of the business model of Auxilium Pharmaceuticals, Inc. including a breakdown and examination of key business segments
- Five-year financial information and charts, including balance sheet, income statement, cash flows, market capitalization and multiples, and key ratios for Auxilium Pharmaceuticals, Inc.
- Intelligence on Auxilium Pharmaceuticals, Inc.nv’s mergers and acquisitions (M&A), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Auxilium Pharmaceuticals, Inc., such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends
Highlights:
Auxilium Pharmaceuticals Inc. (Auxilium or 'the company') is a specialty biopharmaceutical company engaged in the development and marketing of pharmaceutical products that focus on urology and sexual health. It currently markets Testim for the treatment of hypogonadism; and Xiaflex for Dupuytren's contracture patients with a palpable cord. The company operates primarily in the US, where it is headquartered in Pennsylvania. It employed 526 people as of December 31, 2012. The company recorded revenues of $395.3 million during the financial year ended December 2012 (FY2012), an increase of 49.5% over FY2011. The operating profit of the company was $85.5 million in FY2012, as compared to an operating loss of $33.2 million in FY2011. The net profit was $85.9 million in FY2012, as compared to a net loss of $32.9 million in FY2011.
Reasons to Purchase:
- Gain understanding of Auxilium Pharmaceuticals, Inc. and the factors that influence its strategies
- Track strategic initiatives of the company and latest corporate news and actions
- Assess Auxilium Pharmaceuticals, Inc. as a prospective partner, vendor or supplier
- Support sales activities by understanding your customers' businesses better
- Stay up to date on Auxilium Pharmaceuticals, Inc.’s business structure, strategy and prospects
Features:
- Detailed information on Auxilium Pharmaceuticals, Inc. required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Auxilium Pharmaceuticals, Inc. in the form of a SWOT analysis
- An in-depth view of the business model of Auxilium Pharmaceuticals, Inc. including a breakdown and examination of key business segments
- Five-year financial information and charts, including balance sheet, income statement, cash flows, market capitalization and multiples, and key ratios for Auxilium Pharmaceuticals, Inc.
- Intelligence on Auxilium Pharmaceuticals, Inc.nv’s mergers and acquisitions (M&A), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Auxilium Pharmaceuticals, Inc., such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends
Highlights:
Auxilium Pharmaceuticals Inc. (Auxilium or 'the company') is a specialty biopharmaceutical company engaged in the development and marketing of pharmaceutical products that focus on urology and sexual health. It currently markets Testim for the treatment of hypogonadism; and Xiaflex for Dupuytren's contracture patients with a palpable cord. The company operates primarily in the US, where it is headquartered in Pennsylvania. It employed 526 people as of December 31, 2012. The company recorded revenues of $395.3 million during the financial year ended December 2012 (FY2012), an increase of 49.5% over FY2011. The operating profit of the company was $85.5 million in FY2012, as compared to an operating loss of $33.2 million in FY2011. The net profit was $85.9 million in FY2012, as compared to a net loss of $32.9 million in FY2011.
Reasons to Purchase:
- Gain understanding of Auxilium Pharmaceuticals, Inc. and the factors that influence its strategies
- Track strategic initiatives of the company and latest corporate news and actions
- Assess Auxilium Pharmaceuticals, Inc. as a prospective partner, vendor or supplier
- Support sales activities by understanding your customers' businesses better
- Stay up to date on Auxilium Pharmaceuticals, Inc.’s business structure, strategy and prospects
Copyright © FriedlNet. You may share using our tools Please don't cut content from FriedlNet and redistribute by email or post to the web.
Company Snapshot
Auxilium Pharmaceuticals, Inc.: Company Overview
Auxilium Pharmaceuticals, Inc.: Overview and Key Facts
Auxilium Pharmaceuticals, Inc.: Overview
Auxilium Pharmaceuticals, Inc.: Key Facts
Auxilium Pharmaceuticals, Inc.: Key Employees
Auxilium Pharmaceuticals, Inc.: Key Employee Biographies
Auxilium Pharmaceuticals, Inc.: Major Products and Services
Auxilium Pharmaceuticals, Inc.: Company History
Auxilium Pharmaceuticals, Inc.: Management Statement
Auxilium Pharmaceuticals, Inc.: Company Analysis
Auxilium Pharmaceuticals, Inc.: Business Description
Auxilium Pharmaceuticals, Inc.: SWOT Analysis
Auxilium Pharmaceuticals, Inc.: SWOT Overview
Auxilium Pharmaceuticals, Inc.: Strengths
Auxilium Pharmaceuticals, Inc.: Weaknesses
Auxilium Pharmaceuticals, Inc.: Opportunities
Auxilium Pharmaceuticals, Inc.: Threats
Auxilium Pharmaceuticals, Inc.: Financial Analysis
Auxilium Pharmaceuticals, Inc.: Financial Overview
Auxilium Pharmaceuticals, Inc.: Five Year Company Financials
Auxilium Pharmaceuticals, Inc.: Key Income Statement Data
Auxilium Pharmaceuticals, Inc.: Key Balance Sheet Data
Auxilium Pharmaceuticals, Inc.: Key Cash Flow Data
Auxilium Pharmaceuticals, Inc.: Key Market Data
Auxilium Pharmaceuticals, Inc.: Valuation Ratios
Auxilium Pharmaceuticals, Inc.: Profitability Ratios
Auxilium Pharmaceuticals, Inc.: Management Efficiency Ratios
Auxilium Pharmaceuticals, Inc.: Financial Strength Ratios
Auxilium Pharmaceuticals, Inc.: Operational Efficiency Ratios
Auxilium Pharmaceuticals, Inc.: Others
Auxilium Pharmaceuticals, Inc.: Corporate Financial Deals Activity
Auxilium Pharmaceuticals, Inc.: Financial Deals Overview
Auxilium Pharmaceuticals, Inc.: Targets and Partners
Auxilium Pharmaceuticals, Inc.: Top Deals 2009 - 2013YTD*
Auxilium Pharmaceuticals, Inc.: Advisors
Auxilium Pharmaceuticals, Inc.: Top Legal Advisors
Auxilium Pharmaceuticals, Inc.: Top Financial Advisors
Auxilium Pharmaceuticals, Inc.: Mergers and Acquisitions
Auxilium Pharmaceuticals, Inc.: Capital Raising
Auxilium Pharmaceuticals, Inc.: Partnership
Auxilium Pharmaceuticals, Inc.: Recent Developments
Auxilium Pharmaceuticals, Inc.: News and Events Summary
Auxilium Pharmaceuticals, Inc.: Business Expansion
Auxilium Pharmaceuticals, Inc.: Corporate Governance
Auxilium Pharmaceuticals, Inc.: Financial Deals
Auxilium Pharmaceuticals, Inc.: Financial Performance
Auxilium Pharmaceuticals, Inc.: Regulatory and Legal Events
Auxilium Pharmaceuticals, Inc.: Research & Development
Auxilium Pharmaceuticals, Inc.: Strategy and Operations
Appendix
Contact Us
Methodology
Definitions
List of Tables
Table 1: Auxilium Pharmaceuticals, Inc.: Key Facts
Table 2: Auxilium Pharmaceuticals, Inc.: Key Employees
Table 3: Auxilium Pharmaceuticals, Inc.: Key Income Statement Data
Table 4: Auxilium Pharmaceuticals, Inc.: Key Balance Sheet Data
Table 5: Auxilium Pharmaceuticals, Inc.: Key Cash Flow Data
Table 6: Auxilium Pharmaceuticals, Inc.: Key Market Data
Table 7: Auxilium Pharmaceuticals, Inc.: Key Growth Ratios
Table 8: Auxilium Pharmaceuticals, Inc.: Valuation Ratios
Table 9: Auxilium Pharmaceuticals, Inc.: Profitability Ratios
Table 10: Auxilium Pharmaceuticals, Inc.: Management Efficiency Ratios
Table 11: Auxilium Pharmaceuticals, Inc.: Financial Strength Ratios
Table 12: Auxilium Pharmaceuticals, Inc.: Operational Efficiency Ratios
Table 13: Auxilium Pharmaceuticals, Inc.: Others
Table 14: Auxilium Pharmaceuticals, Inc.: Deal Activity by Deal Type - Volume (TTM*)
Table 15: Auxilium Pharmaceuticals, Inc.: M&A Activity by Geography (TTM*)
Table 16: Auxilium Pharmaceuticals, Inc.: Deal Activity by Deal Type - Volume (2009 - YTD*2013)
Table 17: Auxilium Pharmaceuticals, Inc.: M&A Average Deal Size - Value (US$m)
Table 18: Auxilium Pharmaceuticals, Inc.: Targets and Partners
Table 19: Auxilium Pharmaceuticals, Inc.: Top Deals 2009 - 2013YTD*
Table 20: Auxilium Pharmaceuticals, Inc.: Legal Advisor Ranking by Value (US$m)
Table 21: Auxilium Pharmaceuticals, Inc.: Financial Advisor Ranking by Value (US$m)
Table 22: Auxilium Pharmaceuticals, Inc.: M&A Volume and Value Trend (2009 - YTD*2013)
Table 23: Auxilium Pharmaceuticals, Inc.: M&A Activity by Geography (2009 - YTD*2013)
Table 24: Auxilium Pharmaceuticals, Inc.: Capital Raising Volume and Value Trend (2009 - YTD*2013)
Table 25: Auxilium Pharmaceuticals, Inc.: Capital Raising by Deal Type (2009 - YTD*2013)
Table 26: Auxilium Pharmaceuticals, Inc.: Partnership Volume and Value Trend (2009 - YTD*2013)
Table 27: Auxilium Pharmaceuticals, Inc.: Partnership Trend by Deal Type (2009 - YTD*2013)
Table 28: Auxilium Pharmaceuticals, Inc.: News and Events Summary
Table 29: Auxilium Pharmaceuticals, Inc.: Business Expansion
Table 30: Auxilium Pharmaceuticals, Inc.: Corporate Governance
Table 31: Auxilium Pharmaceuticals, Inc.: Financial Deals
Table 32: Auxilium Pharmaceuticals, Inc.: Financial Performance
Table 33: Auxilium Pharmaceuticals, Inc.: Regulatory and Legal Events
Table 34: Auxilium Pharmaceuticals, Inc.: Research & Development
Table 35: Auxilium Pharmaceuticals, Inc.: Strategy and Operations
List of Figures
Figure 1: Auxilium Pharmaceuticals, Inc.: Revenue to Net Income (2007-2011)
Figure 2: Auxilium Pharmaceuticals, Inc.: Revenue/Employee to Net Income/Employee (2007-2011)
Figure 3: Auxilium Pharmaceuticals, Inc.: Current Assets to Current Liabilities (2007-2011)
Figure 4: Auxilium Pharmaceuticals, Inc.: Assets, Liabilities to Total Equity (2007-2011)
Figure 5: Auxilium Pharmaceuticals, Inc.: Free Cash Flow to Cash from Operating Activities (2007-2011)
Figure 6: Auxilium Pharmaceuticals, Inc.: Net Change in Cash (2007-2011)
Figure 7: Auxilium Pharmaceuticals, Inc.: Market Capitalization to Year-end Share Price (2007-2011)
Figure 8: Auxilium Pharmaceuticals, Inc.: Enterprise Value (2007-2011)
Figure 9: Auxilium Pharmaceuticals, Inc.: Deal Activity by Deal Type - Volume (TTM*)
Figure 10: Auxilium Pharmaceuticals, Inc.: M&A Activity by Geography (TTM*)
Figure 11: Auxilium Pharmaceuticals, Inc.: Deal Activity by Deal Type - Volume (2009 - YTD*2013)
Figure 12: Auxilium Pharmaceuticals, Inc.: M&A Average Deal Size - Value (US$m)
Figure 13: Auxilium Pharmaceuticals, Inc.: M&A Volume and Value Trend (2009 - YTD*2013)
Figure 14: Auxilium Pharmaceuticals, Inc.: M&A Activity by Geography (2009 - YTD*2013)
Figure 15: Auxilium Pharmaceuticals, Inc.: Capital Raising Volume and Value Trend (2009 - YTD*2013)
Figure 16: Auxilium Pharmaceuticals, Inc.: Capital Raising by Deal Type (2009 - YTD*2013)
Figure 17: Auxilium Pharmaceuticals, Inc.: Partnership Volume and Value Trend (2009 - YTD*2013)
Figure 18: Auxilium Pharmaceuticals, Inc.: Partnership Trend by Deal Type (2009 - YTD*2013)
Auxilium Pharmaceuticals, Inc.: Company Overview
Auxilium Pharmaceuticals, Inc.: Overview and Key Facts
Auxilium Pharmaceuticals, Inc.: Overview
Auxilium Pharmaceuticals, Inc.: Key Facts
Auxilium Pharmaceuticals, Inc.: Key Employees
Auxilium Pharmaceuticals, Inc.: Key Employee Biographies
Auxilium Pharmaceuticals, Inc.: Major Products and Services
Auxilium Pharmaceuticals, Inc.: Company History
Auxilium Pharmaceuticals, Inc.: Management Statement
Auxilium Pharmaceuticals, Inc.: Company Analysis
Auxilium Pharmaceuticals, Inc.: Business Description
Auxilium Pharmaceuticals, Inc.: SWOT Analysis
Auxilium Pharmaceuticals, Inc.: SWOT Overview
Auxilium Pharmaceuticals, Inc.: Strengths
Auxilium Pharmaceuticals, Inc.: Weaknesses
Auxilium Pharmaceuticals, Inc.: Opportunities
Auxilium Pharmaceuticals, Inc.: Threats
Auxilium Pharmaceuticals, Inc.: Financial Analysis
Auxilium Pharmaceuticals, Inc.: Financial Overview
Auxilium Pharmaceuticals, Inc.: Five Year Company Financials
Auxilium Pharmaceuticals, Inc.: Key Income Statement Data
Auxilium Pharmaceuticals, Inc.: Key Balance Sheet Data
Auxilium Pharmaceuticals, Inc.: Key Cash Flow Data
Auxilium Pharmaceuticals, Inc.: Key Market Data
Auxilium Pharmaceuticals, Inc.: Valuation Ratios
Auxilium Pharmaceuticals, Inc.: Profitability Ratios
Auxilium Pharmaceuticals, Inc.: Management Efficiency Ratios
Auxilium Pharmaceuticals, Inc.: Financial Strength Ratios
Auxilium Pharmaceuticals, Inc.: Operational Efficiency Ratios
Auxilium Pharmaceuticals, Inc.: Others
Auxilium Pharmaceuticals, Inc.: Corporate Financial Deals Activity
Auxilium Pharmaceuticals, Inc.: Financial Deals Overview
Auxilium Pharmaceuticals, Inc.: Targets and Partners
Auxilium Pharmaceuticals, Inc.: Top Deals 2009 - 2013YTD*
Auxilium Pharmaceuticals, Inc.: Advisors
Auxilium Pharmaceuticals, Inc.: Top Legal Advisors
Auxilium Pharmaceuticals, Inc.: Top Financial Advisors
Auxilium Pharmaceuticals, Inc.: Mergers and Acquisitions
Auxilium Pharmaceuticals, Inc.: Capital Raising
Auxilium Pharmaceuticals, Inc.: Partnership
Auxilium Pharmaceuticals, Inc.: Recent Developments
Auxilium Pharmaceuticals, Inc.: News and Events Summary
Auxilium Pharmaceuticals, Inc.: Business Expansion
Auxilium Pharmaceuticals, Inc.: Corporate Governance
Auxilium Pharmaceuticals, Inc.: Financial Deals
Auxilium Pharmaceuticals, Inc.: Financial Performance
Auxilium Pharmaceuticals, Inc.: Regulatory and Legal Events
Auxilium Pharmaceuticals, Inc.: Research & Development
Auxilium Pharmaceuticals, Inc.: Strategy and Operations
Appendix
Contact Us
Methodology
Definitions
List of Tables
Table 1: Auxilium Pharmaceuticals, Inc.: Key Facts
Table 2: Auxilium Pharmaceuticals, Inc.: Key Employees
Table 3: Auxilium Pharmaceuticals, Inc.: Key Income Statement Data
Table 4: Auxilium Pharmaceuticals, Inc.: Key Balance Sheet Data
Table 5: Auxilium Pharmaceuticals, Inc.: Key Cash Flow Data
Table 6: Auxilium Pharmaceuticals, Inc.: Key Market Data
Table 7: Auxilium Pharmaceuticals, Inc.: Key Growth Ratios
Table 8: Auxilium Pharmaceuticals, Inc.: Valuation Ratios
Table 9: Auxilium Pharmaceuticals, Inc.: Profitability Ratios
Table 10: Auxilium Pharmaceuticals, Inc.: Management Efficiency Ratios
Table 11: Auxilium Pharmaceuticals, Inc.: Financial Strength Ratios
Table 12: Auxilium Pharmaceuticals, Inc.: Operational Efficiency Ratios
Table 13: Auxilium Pharmaceuticals, Inc.: Others
Table 14: Auxilium Pharmaceuticals, Inc.: Deal Activity by Deal Type - Volume (TTM*)
Table 15: Auxilium Pharmaceuticals, Inc.: M&A Activity by Geography (TTM*)
Table 16: Auxilium Pharmaceuticals, Inc.: Deal Activity by Deal Type - Volume (2009 - YTD*2013)
Table 17: Auxilium Pharmaceuticals, Inc.: M&A Average Deal Size - Value (US$m)
Table 18: Auxilium Pharmaceuticals, Inc.: Targets and Partners
Table 19: Auxilium Pharmaceuticals, Inc.: Top Deals 2009 - 2013YTD*
Table 20: Auxilium Pharmaceuticals, Inc.: Legal Advisor Ranking by Value (US$m)
Table 21: Auxilium Pharmaceuticals, Inc.: Financial Advisor Ranking by Value (US$m)
Table 22: Auxilium Pharmaceuticals, Inc.: M&A Volume and Value Trend (2009 - YTD*2013)
Table 23: Auxilium Pharmaceuticals, Inc.: M&A Activity by Geography (2009 - YTD*2013)
Table 24: Auxilium Pharmaceuticals, Inc.: Capital Raising Volume and Value Trend (2009 - YTD*2013)
Table 25: Auxilium Pharmaceuticals, Inc.: Capital Raising by Deal Type (2009 - YTD*2013)
Table 26: Auxilium Pharmaceuticals, Inc.: Partnership Volume and Value Trend (2009 - YTD*2013)
Table 27: Auxilium Pharmaceuticals, Inc.: Partnership Trend by Deal Type (2009 - YTD*2013)
Table 28: Auxilium Pharmaceuticals, Inc.: News and Events Summary
Table 29: Auxilium Pharmaceuticals, Inc.: Business Expansion
Table 30: Auxilium Pharmaceuticals, Inc.: Corporate Governance
Table 31: Auxilium Pharmaceuticals, Inc.: Financial Deals
Table 32: Auxilium Pharmaceuticals, Inc.: Financial Performance
Table 33: Auxilium Pharmaceuticals, Inc.: Regulatory and Legal Events
Table 34: Auxilium Pharmaceuticals, Inc.: Research & Development
Table 35: Auxilium Pharmaceuticals, Inc.: Strategy and Operations
List of Figures
Figure 1: Auxilium Pharmaceuticals, Inc.: Revenue to Net Income (2007-2011)
Figure 2: Auxilium Pharmaceuticals, Inc.: Revenue/Employee to Net Income/Employee (2007-2011)
Figure 3: Auxilium Pharmaceuticals, Inc.: Current Assets to Current Liabilities (2007-2011)
Figure 4: Auxilium Pharmaceuticals, Inc.: Assets, Liabilities to Total Equity (2007-2011)
Figure 5: Auxilium Pharmaceuticals, Inc.: Free Cash Flow to Cash from Operating Activities (2007-2011)
Figure 6: Auxilium Pharmaceuticals, Inc.: Net Change in Cash (2007-2011)
Figure 7: Auxilium Pharmaceuticals, Inc.: Market Capitalization to Year-end Share Price (2007-2011)
Figure 8: Auxilium Pharmaceuticals, Inc.: Enterprise Value (2007-2011)
Figure 9: Auxilium Pharmaceuticals, Inc.: Deal Activity by Deal Type - Volume (TTM*)
Figure 10: Auxilium Pharmaceuticals, Inc.: M&A Activity by Geography (TTM*)
Figure 11: Auxilium Pharmaceuticals, Inc.: Deal Activity by Deal Type - Volume (2009 - YTD*2013)
Figure 12: Auxilium Pharmaceuticals, Inc.: M&A Average Deal Size - Value (US$m)
Figure 13: Auxilium Pharmaceuticals, Inc.: M&A Volume and Value Trend (2009 - YTD*2013)
Figure 14: Auxilium Pharmaceuticals, Inc.: M&A Activity by Geography (2009 - YTD*2013)
Figure 15: Auxilium Pharmaceuticals, Inc.: Capital Raising Volume and Value Trend (2009 - YTD*2013)
Figure 16: Auxilium Pharmaceuticals, Inc.: Capital Raising by Deal Type (2009 - YTD*2013)
Figure 17: Auxilium Pharmaceuticals, Inc.: Partnership Volume and Value Trend (2009 - YTD*2013)
Figure 18: Auxilium Pharmaceuticals, Inc.: Partnership Trend by Deal Type (2009 - YTD*2013)
Copyright © FriedlNet. You may share using our tools Please don't cut content from FriedlNet and redistribute by email or post to the web.